
GLP-1 drugs: India’s regulatory authorities take firm steps to prevent unsupervised use
New Delhi, April 1 (IANS) The Drug Controller General of India has stepped up regulatory surveillance against unauthorised sale and promotion of type 2 diabetes drugs also known as GLP-1 drugs, the government said on Wednesday.In recent weeks, 49 businesses were audited and inspected across the country, including online pharmacy warehouses, drug wholesalers, retailers, and weight loss clinics, an official statement said.These inspections spanned multiple regions across India and focused on identifying violations related to unauthorised sale, improper prescription practices, and misleading marketing.The government also issued notices to those found breaking the rules. Stricter inspections and surveillance will continue in the coming weeks. Businesses that break the rules will face license c...









